1. Home
  2. NNE vs ABVX Comparison

NNE vs ABVX Comparison

Compare NNE & ABVX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NNE
  • ABVX
  • Stock Information
  • Founded
  • NNE 2022
  • ABVX 2013
  • Country
  • NNE United States
  • ABVX France
  • Employees
  • NNE N/A
  • ABVX N/A
  • Industry
  • NNE
  • ABVX
  • Sector
  • NNE
  • ABVX
  • Exchange
  • NNE NYSE
  • ABVX Nasdaq
  • Market Cap
  • NNE 718.5M
  • ABVX 722.3M
  • IPO Year
  • NNE 2024
  • ABVX N/A
  • Fundamental
  • Price
  • NNE $28.58
  • ABVX $7.60
  • Analyst Decision
  • NNE Strong Buy
  • ABVX Strong Buy
  • Analyst Count
  • NNE 2
  • ABVX 6
  • Target Price
  • NNE $58.00
  • ABVX $38.67
  • AVG Volume (30 Days)
  • NNE 4.2M
  • ABVX 142.2K
  • Earning Date
  • NNE 02-14-2025
  • ABVX 09-09-2024
  • Dividend Yield
  • NNE N/A
  • ABVX N/A
  • EPS Growth
  • NNE N/A
  • ABVX N/A
  • EPS
  • NNE N/A
  • ABVX N/A
  • Revenue
  • NNE N/A
  • ABVX $9,676,417.00
  • Revenue This Year
  • NNE N/A
  • ABVX $31.67
  • Revenue Next Year
  • NNE N/A
  • ABVX $1,189.66
  • P/E Ratio
  • NNE N/A
  • ABVX N/A
  • Revenue Growth
  • NNE N/A
  • ABVX 100.87
  • 52 Week Low
  • NNE $3.25
  • ABVX $7.00
  • 52 Week High
  • NNE $37.51
  • ABVX $17.02
  • Technical
  • Relative Strength Index (RSI)
  • NNE N/A
  • ABVX 38.69
  • Support Level
  • NNE N/A
  • ABVX $7.00
  • Resistance Level
  • NNE N/A
  • ABVX $8.18
  • Average True Range (ATR)
  • NNE 0.00
  • ABVX 0.49
  • MACD
  • NNE 0.00
  • ABVX 0.01
  • Stochastic Oscillator
  • NNE 0.00
  • ABVX 32.43

About NNE NANO NUCLEAR ENERGY INC

Nano Nuclear Energy Inc is an early-stage nuclear energy company developing smaller, cheaper, and safer advanced portable clean energy solutions. It is focused on four business lines as part of development: Micro Nuclear Reactor Business is developing the next-generation nuclear microreactors, in particular ZEUS, a solid core battery reactor, and ODIN, a low-pressure salt coolant reactor. Fuel Fabrication Business, Fuel Transportation Business and Nuclear Consultation Services.

About ABVX Abivax SA American

Abivax SA is a France-based clinical-stage biotechnology company focused on developing therapeutics that harness the body's natural regulatory mechanisms to stabilize the immune response in patients with chronic inflammatory diseases. They are evaluating its drug candidate, obefazimod, in Phase 3 clinical trials for the treatment of adults with moderately to severely active ulcerative colitis. Its initial focus is on inflammatory bowel diseases, chronic conditions involving inflammation of the gastrointestinal tract, of which the two most common forms are UC and CD.

Share on Social Networks: